Volume 28, Issue 6 pp. 2138-2141
CASE STUDY

Neuropathy of the phrenic nerve associated with antiganglioside antibodies

Anouk Serrien

Corresponding Author

Anouk Serrien

Department of Neurology, University Hospitals Leuven, Leuven, Belgium

Correspondence

Anouk Serrien, Department of Neurology, University Hospitals Leuven, Leuven, Belgium.

Email: [email protected]

Contribution: Conceptualization (supporting), Writing - original draft (lead)

Search for more papers by this author
Katrien Sanders

Katrien Sanders

Department of Neurology, University Hospitals Leuven, Leuven, Belgium

Department of Neurology, GZA Hospitals, Antwerp, Belgium

Contribution: Conceptualization (equal), Writing - review & editing (supporting)

Search for more papers by this author
Kristl G. Claeys

Kristl G. Claeys

Department of Neurology, University Hospitals Leuven, Leuven, Belgium

Laboratory for Muscle Diseases and Neuropathies, Department of Neurosciences and Leuven Brain Institute (LBI), KU Leuven, Leuven, Belgium

Contribution: Writing - review & editing (supporting)

Search for more papers by this author
Koen Poesen

Koen Poesen

Laboratory Medicine, University Hospitals Leuven, Leuven, Belgium

Laboratory for Molecular Neurobiomarker Research, Department of Neurosciences and Leuven Brain Institute (LBI), KU Leuven, Leuven, Belgium

Contribution: Resources (equal)

Search for more papers by this author
Dries Testelmans

Dries Testelmans

Department of Pneumology, University Hospitals Leuven, Leuven, Belgium

Contribution: Resources (equal), Writing - review & editing (supporting)

Search for more papers by this author
Philip Van Damme

Philip Van Damme

Department of Neurology, University Hospitals Leuven, Leuven, Belgium

Laboratory of Neurobiology, Department of Neurosciences and Leuven Brain Institute (LBI), Leuven, Belgium

Center for Brain & Disease Research, VIB, Leuven, Belgium

Contribution: Conceptualization (lead), Writing - review & editing (lead)

Search for more papers by this author
First published: 08 March 2021

Abstract

Background and purpose

Antiganglioside antibodies have been implicated in several autoimmune-mediated neuropathies, and binding of these antibodies can result in inflammatory changes of the nerves. Diaphragmatic paralysis is a rare condition, mostly arising from diseases affecting the phrenic nerve, neuromuscular junction, or skeletal muscle.

Objectives

In this case series, we identified five patients with diaphragmatic paralysis due to unilateral or bilateral neuropathy of the phrenic nerve associated with the presence of antiganglioside antibodies (immunoglobulin G anti-GT1a antibodies and immunoglobulin M anti-GM1 antibodies).

Discussion

The combination of an isolated phrenic nerve palsy with anti-GM1 antibodies has only once been described. On the other hand, the association of anti-GT1a antibodies with phrenic nerve palsy has never been reported before.

Conclusions

We report an association between phrenic nerve palsy and the presence of antiganglioside antibodies, but it remains unclear if there is a causal relationship. Further studies are needed to explore this matter.

DATA AVAILABILITY STATEMENT

The data that support the findings of this study are available on request from the corresponding author. The data are not publicly available due to privacy or ethical restrictions.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.